Xp21 Microdeletion Syndrome
Description
Xp21 microdeletion syndrome is a rare chromosomal anomaly characterized by complex glycerol kinase deficiency, congenital adrenal hypoplasia, intellectual disability and/or Duchenne muscular dystrophy that usually affect males. The clinical features depend on the deletion size and the number and type of involved genes.
Clinical Features
Top most frequent phenotypes and symptoms related to Xp21 Microdeletion Syndrome
- Intellectual disability
- Seizures
- Global developmental delay
- Growth delay
- Hypertelorism
- Strabismus
- Muscle weakness
- Spasticity
- Myopathy
- Clinodactyly
And another 34 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Xp21 Microdeletion Syndrome Is also known as xp21 contiguous gene deletion syndrome, glycerol kinase deficiency-contiguous gene syndrome, del(x)(p21), complex glycerol kinase deficiency.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Sources and references
You can check the following sources for additional information.
OMIM ORPHANET Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like USHER SYNDROME, TYPE IIIA; USH3A MICROCEPHALY 1, PRIMARY, AUTOSOMAL RECESSIVE; MCPH1 CARDIOMYOPATHY, DILATED, 1A; CMD1A